Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$1.86 - $3.36 $23,250 - $42,000
12,500 New
12,500 $29,000
Q3 2021

Nov 12, 2021

SELL
$1.52 - $3.82 $68,400 - $171,900
-45,000 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$2.66 - $3.47 $36,974 - $48,233
-13,900 Reduced 23.6%
45,000 $140,000
Q1 2021

May 14, 2021

BUY
$1.98 - $5.36 $116,622 - $315,704
58,900 New
58,900 $178,000
Q1 2019

May 15, 2019

SELL
$1.18 - $1.91 $12,862 - $20,819
-10,900 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$1.01 - $2.78 $11,009 - $30,301
10,900 New
10,900 $13,000

Others Institutions Holding INFI

About INFINITY PHARMACEUTICALS, INC.


  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.